Treg cells are thought to modulate the anti-tumor immune response by suppressing the activity of cytotoxic CD8+ T cells through direct cell-cell contact and/or secretion of transforming growth factor β (TGFβ). The gene discussed is CD8A; the disease is neoplasm.